# Alveolar Macrophage Programming Following Endotoxin Exposure

> **NCT03859050** · NA · RECRUITING · sponsor: **National Jewish Health** · enrollment: 25 (estimated)

## Conditions studied

- ARDS, Human

## Interventions

- **OTHER:** bronchoscopy with intrabronchial administration of lipopolysaccharide

## Key facts

- **NCT ID:** NCT03859050
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-18
- **Primary completion:** 2029-07
- **Final completion:** 2032-07
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03859050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03859050, "Alveolar Macrophage Programming Following Endotoxin Exposure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03859050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*